Almotriptan versus rizatriptan in patients with migraine in Spain

Headache

Volumn 43, Issue 7, 2003, Pages 734-741

  Leira, Rogelio ^a   Dualde, Elena ^b   Del Barrio, Horacio ^c   Machuca, Manuel ^d   López Gil, Arturo ^e  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d Hospital Clinico Universitario   (Spain)

^e AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

Almotriptan; Consumption survey; Migraine; Rizatriptan; Triptan

Indexed keywords

ALMOTRIPTAN; RIZATRIPTAN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; PAIN ASSESSMENT; PATIENT SATISFACTION; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; SPAIN; TABLET; TREATMENT PLANNING;

ADULT; FEMALE; HUMANS; INDOLES; MALE; MIGRAINE DISORDERS; PAIN MEASUREMENT; PATIENT SATISFACTION; SEROTONIN AGONISTS; SPAIN; TRIAZOLES; TRYPTAMINES;

EID: 0042028101     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2003.03131.x     Document Type: Article

References (8)

1. Ferrari MD. The economic burden of migraine to society. Pharmacoeconomics. 1998;13:667-676.
2. Björk S, Roos P. Economic Aspects of Migraine in Sweden. Lund, Sweden: Lund Institute for Health Economics; 1991. Working Paper 8.
3. Tepper S, Ward T, Maurer C. Patient-reported tablet utilization of zolmitriptan and sumatriptan [abstract]. Headache. 1998;38:408-409.
4. Pascual J, Fité B, López-Gil A. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain. Headache. 2002;42:93-98.
5. Hochberg Y. A sharper Bonferroni procedure for multiple test of significance. Biometrika. 1998;75:800-802.
6. SAS Institute Inc. SAS/STAT User's Guide. Version 8.2. Cary, NC: SAS Institute Inc; 2000.
7. Belsey J. Reconciling effectiveness and tolerability in oral triptan therapy: a quantitative approach to decision making in migraine management. J Clin Res. 2001;4:105-125.
8. 1B/1D agonists) in acute migraine management: a meta-analysis of 53 trials. Lancet. 2001;358:1668-1675.